Rivian Automotive’s upcoming R2 model could capitalize on an electric vehicle demand rebound in the U.S., according to TD Cowen.
TD Cowen downgrades Novo Nordisk on concerns over semaglutide patent loss, pipeline outlook
TD Cowen still sees shares of Novo Nordisk adding 6% from here.
This cybersecurity stock is positioned to capitalize on AI tailwinds, says Morgan Stanley
The bank upgraded the cybersecurity stock to overweight from equal weight.
Tuesday’s big stock stories: What’s likely to move the market in the next trading session
The Dow bounced from a loss of almost 900 points to posting a nearly 240-point gain on Monday after Trump indicated an end may be in sight for the Iran war.
Oil was last above $100 back in 2022. These were the best and worst stocks to own during that stretch
A handful of stocks put on a standout performance the last time oil prices surged over $100 a barrel.
Higher energy prices mean this stock’s big dividend will get even larger. Investor Harrington is a buyer
This stock already pays a hefty 7.1% dividend that the company expects to grow by 3% to 5% this year.
Fears of 1970s-style stagflation arise with oil spike to $100. How big a threat is it?
High inflation and slow growth present a double threat, as measures like interest rate cuts and government spending only aggravate inflation.
When will the selling stop? Jay Woods and other traders are watching this key S&P 500 level
The broad market index is fast approaching its 200-day moving average, which is at 6,582.
The $100 oil playbook: How pro investors are investing around this energy shock
Many say the focus now is on maintaining exposure to equities while diversifying across sectors and regions that can better withstand inflation and volatility.
Biotech is resistant to AI disruption. Josh Brown likes these two stocks in the industry
Josh Brown and Sean Russo take a look at the biotech stocks in their Best Stocks list.